abstract |
The present invention is directed to imidazolinone derivatives that are antagonists of CGRP receptors and are useful in the treatment or prevention of diseases involving CGRP, such as migraine. The present invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved. |